ALC.AX - Alcidion Group Limited

ASX - ASX Delayed price. Currency in AUD

Alcidion Group Limited

9 Yarra Street
Level 10
South Yarra, VIC 3141
61 3 8060 6177

IndustryHealth Information Services
Full-time employees

Key executives

NameTitlePayExercisedYear born
Ms. Kate QuirkeMD, CEO & Exec. Director430.25kN/AN/A
Mr. Raymond Howard BlightCo-Founder & Non-Exec. Director397.35kN/AN/A
Mr. Colin Bruce MacKinnonCFO & COO1.1MN/AN/A
Prof. Malcolm PradhanChief Medical Officer, Product Mang. & Exec. Director298.12kN/AN/A
Ms. Tracey HarveyHR Mang.N/AN/AN/A
Amounts are as of 31 December 2019, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Alcidion Group Limited engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision that combines artificial intelligence-based predictive analytics, clinical decision support, and mobile alerts in analytics dashboard; Patientrack, a patient safety and communication systems putting clinicians in control; and Smartpage, a messaging and task management platform that enables hospital staff to communicate and collaborate. It also provides project management, consulting, and support services for digital health projects. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. The company was founded in 2000 and is headquartered in South Yarra, Australia.

Corporate governance

Alcidion Group Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.